 BOCA RATON, Fla.--BUSINESS WIRE--TherapeuticsMD, Inc. NASDAQ: TXMD, an innovative, leading womens healthcare company, today announced that the Centers for Medicare and Medicaid Services CMS confirmed its preliminary recommendation to assign a permanent product-specific Healthcare Common Procedure Coding System HCPCS J Code for ANNOVERA segesterone acetate and ethinyl estradiol vaginal system. As a result, CMS established the new HCPCS Level II code J7294 Segesterone acetate and ethi 